SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 2173979

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 2173979

Global Life Science Analytics Software Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 243 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global life science analytics software market size is expected to reach USD 53.17 Billion in 2034 from USD 13.97 Billion in 2025, growing at a CAGR of 16.01% during 2026-2034.This market is expanding as pharmaceutical companies, biotechnology organizations, healthcare institutions, and research laboratories increasingly rely on data analytics to improve scientific research and operational performance. Life science analytics software enables organizations to manage, analyze, and interpret complex biological, clinical, genomic, and operational datasets. Growing investments in drug discovery, clinical research, precision medicine, and biotechnology innovation are supporting market development. Additionally, the increasing adoption of digital laboratory systems and data-driven research methodologies is encouraging demand for advanced analytical software platforms.

The major growth drivers include increasing clinical trial activities, rising volumes of biological data, and growing adoption of artificial intelligence and machine learning. Life science organizations are using analytics software for clinical data management, drug development, genomic analysis, regulatory reporting, and research optimization. Advancements in cloud computing, predictive modeling, data visualization, and bioinformatics are improving analytical capabilities. Furthermore, the expansion of personalized medicine, biologics manufacturing, and real-world evidence research is increasing the need for integrated data management and analytics solutions.

The future outlook for this market remains highly promising as life sciences increasingly transition toward digital and data-driven research environments. Advancements in generative artificial intelligence, predictive analytics, automated laboratory workflows, and multimodal biological data analysis are expected to create new opportunities. Increasing integration of analytics platforms with electronic health records, clinical research systems, and laboratory information management systems will further strengthen adoption. Additionally, growing investments in precision medicine, pharmaceutical research, and biotechnology infrastructure are likely to support long-term market expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Prescriptive Analytics
  • Descriptive Analytics
  • Predictive Analytics

By Application

  • Research And Development
  • Sales And Marketing Support
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

By Delivery Model

  • On-premise
  • Cloud

By Component

  • Software
  • Services

By End User

  • Pharmaceutical And Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third Party Administrators

COMPANIES PROFILED

  • IQVIA
  • SAS
  • Oracle
  • Veeva Systems
  • Palantir Technologies
  • Cognizant
  • Accenture
  • Clarivate
  • Elsevier
  • Definitive Healthcare
  • Komodo Health
  • Datavant
  • TriNetX
  • Medidata
  • ArisGlobal
  • MasterControl
  • Saama Technologies
  • Benchling
  • Dotmatics
  • Schrodinger
Product Code: VMR112111758

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Prescriptive Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Descriptive Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Predictive Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Research And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sales And Marketing Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Regulatory Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Supply Chain Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY DELIVERY MODEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Delivery Model
  • 6.2. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cloud Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Component
  • 7.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Third Party Administrators Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Application
    • 9.2.3 By Delivery Model
    • 9.2.4 By Component
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Application
    • 9.3.3 By Delivery Model
    • 9.3.4 By Component
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Spain
    • 9.3.11 Russia
    • 9.3.12 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Application
    • 9.4.3 By Delivery Model
    • 9.4.4 By Component
    • 9.4.5 By End User
    • 9.4.6 China
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 India
    • 9.4.10 Australia
    • 9.4.11 South East Asia
    • 9.4.12 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Application
    • 9.5.3 By Delivery Model
    • 9.5.4 By Component
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Application
    • 9.6.3 By Delivery Model
    • 9.6.4 By Component
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 IQVIA
    • 11.2.2 SAS
    • 11.2.3 Oracle
    • 11.2.4 Veeva Systems
    • 11.2.5 Palantir Technologies
    • 11.2.6 Cognizant
    • 11.2.7 Accenture
    • 11.2.8 Clarivate
    • 11.2.9 Elsevier
    • 11.2.10 Definitive Healthcare
    • 11.2.11 Komodo Health
    • 11.2.12 Datavant
    • 11.2.13 TriNetX
    • 11.2.14 Medidata
    • 11.2.15 ArisGlobal
    • 11.2.16 MasterControl
    • 11.2.17 Saama Technologies
    • 11.2.18 Benchling
    • 11.2.19 Dotmatics
    • 11.2.20 Schrodinger
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!